MarketInOut Stock Screener Log In | Sign Up
 

Neuronetics Inc

IEX • Healthcare • Medical Devices • Quote as of 08/24/2026 15:59
Neuronetics Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeIEX
Market Capitalization233.16 mln
Float34.88 mln
Earnings Date11/10/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-3.29
Reliable

Relative Strength

98 / 100
Top performer

Debt / Equity

4.85
Highly leveraged

ROE

-141
Deeply negative

Dividend Yield

0.00%
No dividend

Business Description

Neuronetics develops and sells a brain stimulation device called the NeuroStar Advanced Therapy System, which helps adults suffering from major depression. The treatment works by using magnetic pulses to activate specific areas of the brain linked to mood, and it is performed in a doctor's office without surgery or medication. Neuronetics markets this technology directly to psychiatrists across the United States and in other countries. Founded in 2001, the company is based in Malvern, Pennsylvania.

Key Fundamentals

EPS-0.43
ROE-141
RPS2.22
ROIC-22.78
ROA-22.42
EBITDA, mln-19.71
EV / EBITDA-15.14
EV / EBIT-13.07
Revenue, mln155
EV / Revenue1.92

Financial Strength

Altman Z-Score-2.98
Piotroski F-Score 4 / 9
Beneish M-Score-3.29
Short Ratio4.71
Short % of Float27.16

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -11.62% 6 / 100   
1 Month 65.14% 99 / 100   
2 Months 124% 99 / 100   
6 Months 124% 98 / 100   
1 Year -12.95% 27 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us